Finance

Lists
1789:TPE
ScinoPharm Taiwan Ltd
NT$19,20
-0,52%
(-0,100) 1D
20 Okt., 13:30:03 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1789...
Open
NT$19,00
High
NT$19,55
Low
NT$19,00
Mkt. cap
15,18 mjd
Avg. vol.
493,48 k
Volume
379,56 k
Dividend
1,51%
Quarterly dividend
NT$0,07
Ex-dividend date
02 Jul. 2026
P/E ratio
403,53
52-wk high
NT$29,10
52-wk low
NT$16,70
EPS
NT$0,05
Shares outstanding
790,74 m
No. of employees
1 k
Open
NT$19,00
High
NT$19,55
Low
NT$19,00
Mkt. cap
15,18 mjd
Avg. vol.
493,48 k
Volume
379,56 k
Dividend
1,51%
Quarterly dividend
NT$0,07
Ex-dividend date
02 Jul. 2026
P/E ratio
403,53
52-wk high
NT$29,10
52-wk low
NT$16,70
EPS
NT$0,05
Shares outstanding
790,74 m
No. of employees
1 k
News stories
From web sources and news partners
About ScinoPharm Taiwan Ltd
CEO-
Employees1,01 k
Founded11 Nov. 1997
Headquarters-
SectorPharmaceutical industry
Websitescinopharm.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
721,50 m
1,01 mjd
659,71 m
678,50 m
Cost of goods sold
505,66 m
674,97 m
438,17 m
543,87 m
Cost of revenue
505,66 m
674,97 m
438,17 m
543,87 m
Research and development expenses
121,40 m
195,17 m
85,54 m
86,45 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
114,03 m
128,12 m
112,89 m
113,74 m
Operating expense
235,45 m
325,04 m
213,05 m
200,04 m
Total operating expenses
741,11 m
1,00 mjd
651,22 m
743,91 m
Operating income
-19,62 m
8,03 m
8,49 m
-65,41 m
Other non operating income
-9,89 m
19,92 m
-7,76 m
3,85 m
EBT including unusual items
19,18 m
23,96 m
19,32 m
-53,50 m
EBT excluding unusual items
19,28 m
21,96 m
19,35 m
-53,42 m
Income tax expense
3,73 m
-17,32 m
2,80 m
-17,98 m
Effective tax rate
19,46%
-72,27%
14,47%
33,60%
Other operating expenses
-
-
-
-
Net income
15,45 m
41,28 m
16,53 m
-35,53 m
Net profit margin
2,14%
4,10%
2,51%
-5,24%
Earnings per share
0,02
0,05
-
-
Interest and investment income
37,62 m
-
13,03 m
14,10 m
Interest expense
-2,71 m
-16,12 m
-2,97 m
-3,06 m
Net interest expenses
34,92 m
-16,12 m
10,06 m
11,05 m
Depreciation and amortization charges
-
-
-
-
EBITDA
105,83 m
134,08 m
133,63 m
55,46 m
Gain or loss from assets sale
100,00 k
188,00 k
21,00 k
88,00 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme